SLC5A2 and diabetes mellitus: However, despite the use of ACEIs, ARBs, and the concomitant use of SGLT2 inhibitors, the rate of renal deterioration remains high, with more than twice the normal decline in kidney function in patients with diabetes compared to patients without diabetes [13].